Bericht
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
This report provides an analysis of patents covering medicines in trials to treat COVID-19. The aim of the report is to support national patent offices and interested parties in developing countries with information that can serve as guidance for the examination of the claims contained in relevant patents or patent applications. The medicines considered for the patent analysis in this report are remdesivir, ruxolitinib and favipiravir, and the biotherapeutics tocilizumab, siltuximab and sarilumab.
- Sprache
-
Englisch
- Erschienen in
-
Series: Research Paper ; No. 120
Klassifikation
Sozialwissenschaften, Soziologie, Anthropologie
Thema
Access to Medicines
Affordable Medicines
Biotherapeutics
Coronavirus
COVID-19
European Union (EU)
Favipiravir
France
Global Health
Health
India
Intellectual Property
Pandemic
Patent
Public Health
Remdesivir
Ruxolitinib
Sarilumab
Siltuximab
Tocilizumab
United Nations Development Programme (UNDP)
United States (US)
World Intellectual Property Organization (WIPO)
Affordable Medicines
Biotherapeutics
Coronavirus
COVID-19
European Union (EU)
Favipiravir
France
Global Health
Health
India
Intellectual Property
Pandemic
Patent
Public Health
Remdesivir
Ruxolitinib
Sarilumab
Siltuximab
Tocilizumab
United Nations Development Programme (UNDP)
United States (US)
World Intellectual Property Organization (WIPO)
Ereignis
Geistige Schöpfung
(wer)
Ravi, Srividya
Ereignis
Veröffentlichung
(wer)
South Centre
(wo)
Geneva
(wann)
2020
- Handle
- Letzte Aktualisierung
-
20.09.2024, 08:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Bericht
Beteiligte
- Ravi, Srividya
- South Centre
Entstanden
- 2020
Ähnliche Objekte (12)
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Guidelines on patentability and access to medicines
The international debate on generic medicines of biological origin
Regional pooled procurement of medicines in the East African community
Medicines and intellectual property: 10 years of the WHO global strategy
Intellectual property, public health and access to medicines in international organizations
Access to medicines and intellectual property: The contribution of the World Health Organization
The African Regional Intellectual Property Organization (ARIPO) protocol on patents: Implications for access to medicines
Intellectual property in the Trans-Pacific Partnership: Increasing the barriers for the access to affordable medicines
Transition period for TRIPS implementation for LDCs: Implications for local production of medicines in the East African community
The right to health and medicines: The case of recent negotiations on the global strategy on public health, innovation and intellectual property
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Guidelines on patentability and access to medicines
The international debate on generic medicines of biological origin
Regional pooled procurement of medicines in the East African community
Medicines and intellectual property: 10 years of the WHO global strategy
Intellectual property, public health and access to medicines in international organizations
Access to medicines and intellectual property: The contribution of the World Health Organization
The African Regional Intellectual Property Organization (ARIPO) protocol on patents: Implications for access to medicines
Intellectual property in the Trans-Pacific Partnership: Increasing the barriers for the access to affordable medicines
Transition period for TRIPS implementation for LDCs: Implications for local production of medicines in the East African community
The right to health and medicines: The case of recent negotiations on the global strategy on public health, innovation and intellectual property
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Guidelines on patentability and access to medicines
The international debate on generic medicines of biological origin
Regional pooled procurement of medicines in the East African community
Medicines and intellectual property: 10 years of the WHO global strategy
Intellectual property, public health and access to medicines in international organizations
Access to medicines and intellectual property: The contribution of the World Health Organization
The African Regional Intellectual Property Organization (ARIPO) protocol on patents: Implications for access to medicines
Intellectual property in the Trans-Pacific Partnership: Increasing the barriers for the access to affordable medicines
Transition period for TRIPS implementation for LDCs: Implications for local production of medicines in the East African community